Keefe, Bruyette & Woods Rates Crescent Capital BDC (CCAP) buy

Keefe, Bruyette & Woods maintains its buy rating for CCAP, setting a price target of $13, a 16.91% upside from the current price.

By EarningsIQ Research Desk · Published Jun 16, 2026, 12:01 PM EDT · Updated Jun 17, 2026, 1:00 AM EDT

Reviewed by automated data checks against the source data. How we make and check alerts

Keefe, Bruyette & Woods rated Crescent Capital BDC, Inc. ($CCAP) "buy" with a $13 price target on June 16, 2026.

Since the rating, $CCAP is down 0.8% after 1 week, up 1.7% after 1 month and down 16.0% to date (from the $10.59 close on Jun 16, 2026).

CCAP Crescent Capital BDC, Inc.

$8.90 -30.63% year to date

Daily close · Oct 16, 2026

Key Points

Keefe, Bruyette & Woods reiterated its buy rating for CCAP on June 16, 2026, with a target price of $13.
Keefe, Bruyette & Woods's $13 price target implies 16.91% upside from Crescent Capital BDC, Inc.'s ($CCAP) current $11.12 share price.
CCAP's stock is trading near $11.12, reflecting its current market conditions.
Insider buying activity includes purchases by executives like CEO Jason Breaux and President Henry Chung.

Get $CCAP trade alerts by text

We text you when insiders, Congress or big funds trade $CCAP. Free.

Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Crescent Capital BDC, Inc. alert may contain errors. Disclosures

Keefe, Bruyette & Woods reiterated its buy rating on CCAP on June 16, 2026, setting a price target of $13. This action reaffirms the firm's positive outlook on the company's stock.

Other Institutional Activity in CCAP

Among CCAP's institutional investors, Texas County & District Retirement System held steady with 5,001,752 shares valued at about $60.77 million. Blackstone Inc. also maintained its position with 4,205,307 shares worth approximately $51.09 million. Fidelity National Financial, Inc. mirrored this holding with an identical amount of shares and value. Sun Life Financial Inc. held 2,226,308 shares worth $27.05 million. Invesco Ltd. increased its holdings by 369,270 shares to reach a total of 1,028,966 shares, valued at $12.5 million, marking a 56% increase. Ares Management LLC added 30,000 shares, ending with 546,409 shares valued at $6.64 million.

Crescent Capital BDC, Inc. Stock Up 13.7%

Shares of CCAP traded near $11.12. The stock's performance reflects its market dynamics and the broader economic environment affecting its sector.

12-month forecast

$CCAP price target

Crescent Capital BDC, Inc. daily closes and this analyst's $13 target. Not advice.

Insider Buying and Selling at Crescent Capital BDC, Inc.

Recent insider buying activity at CCAP includes several key executives. On May 21, 2026, President Henry Chung purchased 4,500 shares at an average price of $11.45. Chief Executive Officer Jason Breaux bought 5,000 shares on May 20 at $11.19. On May 19, Steven Strandberg acquired 85,000 shares at $11.28. Additionally, Chief Financial Officer Gerhard Lombard bought 1,000 shares at $11.12 on May 18.

Analysts Set New Price Targets

On June 16, 2026, Keefe, Bruyette & Woods maintained its buy rating for CCAP with a $13 price target. Ladenburg Thalmann also maintained a buy rating on May 15, 2026, with a higher target of $15. Oppenheimer downgraded its rating but set a target of $16 on the same date. Wells Fargo maintained a hold rating with a $12 target.

About CCAP

CCAP operates within a sector that is influenced by various market factors. The company is involved in activities that position it within its industry, offering products and services aligned with its strategic goals.

Bottom Line

Keefe, Bruyette & Woods' reiteration of a buy rating on CCAP with a $13 target offers insight into the firm's confidence in the stock. Investors often track these ratings for signs of market sentiment and potential valuation changes. The reiterated rating should be viewed in the context of ongoing market analysis and investor strategy.